We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

224 hedge funds and large institutions have $2.6B invested in Beam Therapeutics in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 74 increasing their positions, 65 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more call options, than puts

Call options by funds: $53.9M | Put options by funds: $15.5M

76% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 25

24% more capital invested

Capital invested by funds: $2.09B → $2.6B (+$509M)

14% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 65

9% more funds holding

Funds holding: 205 → 224 (+19)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.26% less ownership

Funds ownership: 77.81% → 77.55% (-0.26%)

Holders
224
Holders Change
+19
Holders Change %
+9.27%
% of All Funds
3.86%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
44
Increased
74
Reduced
65
Closed
25
Calls
$53.9M
Puts
$15.5M
Net Calls
+$38.4M
Net Calls Change
+$44.4M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$52.9M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$21.4M
3
EAM
Eventide Asset Management
Massachusetts
+$15.2M
4
HRCM
Hood River Capital Management
Florida
+$13.1M
5
NAMA
Nikko Asset Management Americas
New York
+$12.5M

Top Sellers

1
Temasek Holdings
Temasek Holdings
Singapore
-$62.3M
2
State Street
State Street
Massachusetts
-$44.1M
3
AIM
ARK Investment Management
Florida
-$17.2M
4
DTC
Deep Track Capital
Connecticut
-$14.3M
5
Millennium Management
Millennium Management
New York
-$13.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
51
Russell Investments Group
United Kingdom
$4.38M +$105K +1,849 +2%
GC
52
Guggenheim Capital
Illinois
$4.17M -$537K -9,409 -10%
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$4.05M +$500K +8,763 +12%
WP
54
Woodline Partners
California
$3.96M +$4.74M +83,134 New
CS
55
Candriam SCA
Luxembourg
$3.79M – – –
CSS
56
Cubist Systematic Strategies
Connecticut
$3.67M -$7.26M -127,353 -62%
RMCM
57
Reynders McVeigh Capital Management
Massachusetts
$3.57M +$402K +7,039 +10%
California State Teachers Retirement System (CalSTRS)
58
California State Teachers Retirement System (CalSTRS)
California
$3.5M -$9.41K -165 -0.2%
Renaissance Technologies
59
Renaissance Technologies
New York
$3.4M -$11.9M -208,600 -75%
AllianceBernstein
60
AllianceBernstein
Tennessee
$3.34M +$17.1K +300 +0.4%
Susquehanna International Group
61
Susquehanna International Group
Pennsylvania
$3.29M +$302K +5,288 +8%
SAM
62
Sectoral Asset Management
Quebec, Canada
$3.13M +$3.75M +65,700 New
UBS AM
63
UBS AM
Illinois
$2.8M -$375K -6,578 -10%
CS
64
Credit Suisse
Switzerland
$2.76M +$212K +3,725 +7%
State of Wisconsin Investment Board
65
State of Wisconsin Investment Board
Wisconsin
$2.71M -$186K -3,261 -5%
Ameriprise
66
Ameriprise
Minnesota
$2.7M +$3.23M +56,628 New
Legal & General Group
67
Legal & General Group
United Kingdom
$2.57M -$151K -2,640 -5%
TLP
68
Tri Locum Partners
New York
$2.56M +$3.07M +53,754 New
New York State Common Retirement Fund
69
New York State Common Retirement Fund
New York
$2.46M +$88.4K +1,550 +3%
Deutsche Bank
70
Deutsche Bank
Germany
$2.4M +$76.2K +1,335 +3%
TC
71
TwinBeech Capital
New York
$2.39M +$2.86M +50,216 New
TCM
72
Tang Capital Management
California
$2.38M +$2.85M +50,000 New
D.E. Shaw & Co
73
D.E. Shaw & Co
New York
$2.1M +$2.51M +43,995 New
CAM
74
ClariVest Asset Management
California
$2.08M -$148K -2,593 -6%
Connor, Clark & Lunn Investment Management (CC&L)
75
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.03M +$2.44M +42,687 New
1 2
3
4 5

BEAM Hedge Fund Activity: Q3 2022 in Review

224 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q3 2022, worth a combined $2.6B — up 24% from $2.09B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new BEAM positions and 25 closed out — a net gain of 19 holders — while 74 added to existing stakes and 65 trimmed.

The largest buyer was Vanguard Group, adding an estimated $52.9M. The largest seller was Temasek Holdings, cutting an estimated $62.3M.

  • 224 institutional investors held Beam Therapeutics (BEAM) as of Q3 2022, up from 205 in Q2 2022.
  • Funds reported $2.6B of Beam Therapeutics stock for Q3 2022, up 24% quarter-over-quarter.
  • 44 funds opened new Beam Therapeutics positions in Q3 2022 and 25 closed out, a net change of +19 holders.
  • The largest Beam Therapeutics buyer in Q3 2022 was Vanguard Group, an estimated $52.9M added.
  • The largest Beam Therapeutics seller in Q3 2022 was Temasek Holdings, an estimated $62.3M sold.

Based on aggregated 13F filings for Q3 2022.